{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:04:03Z","timestamp":1648580643631},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1979,2,1]],"date-time":"1979-02-01T00:00:00Z","timestamp":286675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1979,2]]},"DOI":"10.1007\/bf01477405","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T22:02:26Z","timestamp":1113429746000},"page":"173-180","source":"Crossref","is-referenced-by-count":2,"title":["Influence of spironolactone on serum corticosteroids in primary hyperaldosteronism"],"prefix":"10.1007","volume":"57","author":[{"given":"U.","family":"Abshagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sp\ufffdrl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Oelkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"307s","volume":"51","author":"U. Abshagen","year":"1976","unstructured":"Abshagen, U., Sp\ufffdrl, S., Sch\ufffdnesh\ufffdfer, M., L'age, M., Oelkers, W.: Influence of spironolactone on endogenous steroid metabolism in man. Clin. Sci. Mol. Med.51, 307s-310s (1976)","journal-title":"Clin. Sci. Mol. Med."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1210\/jcem-44-6-1190","volume":"44","author":"U. Abshagen","year":"1977","unstructured":"Abshagen, U., Sp\ufffdrl, S., Sch\ufffdnesh\ufffdfer, M., Oelkers, W.: Increased plasma 11-deoxycorticosterone during spironolactome medication. J. clin. Endocrinol. Metab.44, 1190?1193 (1977)","journal-title":"J. clin. Endocrinol. Metab."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF01477394","volume":"56","author":"U. Abshagen","year":"1978","unstructured":"Abshagen, U., Sp\ufffdrl, S., Sch\ufffdnesh\ufffdfer, M., L'age, M., Oelkers, W.: Interference of spironolactone therapy with adrenal steroid metabolism in secondary hyperaldosteronism. Klin. Wochenschr.56, 341?349 (1978)","journal-title":"Klin. Wochenschr."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0002-9343(72)90158-1","volume":"53","author":"J. Cain","year":"1972","unstructured":"Cain, J., Tuck, M., Williams, G., Dluhy, R., Rosenoff, S.: The regulation of aldosterone secretion in primary aldosteronism. Am. J. Med.53, 627?637 (1972)","journal-title":"Am. J. Med."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1172\/JCI105402","volume":"45","author":"P. Cannon","year":"1966","unstructured":"Cannon, P., Ames, R., Laragh, J.: Relation between potassium balance and aldosterone secretion in normal subjects, in patients with hypertensive or renal tubular disease. J. clin. Invest.45, 865?872 (1966)","journal-title":"J. clin. Invest."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/endo-99-4-1097","volume":"99","author":"S. Cheng","year":"1976","unstructured":"Cheng, S., Suzuki, K., Sad\ufffde, W.: Effects of spironolactone, canrenone and canrenoate-K on cytochrome P 450 and 11\ufffd- and 18-hydroxylation in bovine and human adrenal cortical mitochondria. Endocrinology99, 1097?1106 (1976)","journal-title":"Endocrinology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0026-0495(77)90026-9","volume":"26","author":"J. Conn","year":"1977","unstructured":"Conn, J., Hinerman, D.: Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies. Metabolism26, 1293?1307 (1977)","journal-title":"Metabolism"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2362.1971.tb00565.x","volume":"2","author":"G. D\ufffdsterdieck","year":"1971","unstructured":"D\ufffdsterdieck, G., McElwee, G.: Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states. Europ. J. clin. Invest.2, 32?38 (1971)","journal-title":"Europ. J. clin. Invest."},{"key":"CR9","first-page":"366","volume":"273","author":"H. Erbler","year":"1972","unstructured":"Erbler, H.: Stimulation of aldosterone production in vitro and its inhibition by spironolactone. Naunyn Schmiedeberg's Arch. Pharmacol.273, 366?375 (1972)","journal-title":"Pharmacol."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00501155","volume":"277","author":"H. Erbler","year":"1973","unstructured":"Erbler, H.: On the mechanism of the inhibitory action of the spironolactone SC 9376 (aldadiene) on the production of corticosteroids in rat adrenals in vitro. Naunyn Schmiedeberg's Arch. Pharmacol.277, 139?149 (1973)","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00501467","volume":"285","author":"H. Erbler","year":"1974","unstructured":"Erbler, H.: Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man. Naunyn Schmiedeberg's Arch. Pharmacol.285, 395?401 (1974)","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00561657","volume":"9","author":"H. Erbler","year":"1976","unstructured":"Erbler, H., Wernze, H., Hilfenhaus, M.: Effect of the aldosterone antagonist canrenone on plasma aldosterone concentration and plasma renin activity, and on the excretion of aldosterone and electrolytes by man. Europ. J. clin. Pharmacol.9, 253?257 (1976)","journal-title":"Europ. J. clin. Pharmacol."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/jcem-37-5-765","volume":"37","author":"A. Ganguly","year":"1973","unstructured":"Ganguly, A., Melada, G., Luetscher, J., Dowdy, A.: Control of plasma aldosterone on primary aldosteronism: distinction between adenoma and hyperplasia. J. clin. Endocrinol. Metab.37, 765?775 (1973)","journal-title":"J. clin. Endocrinol. Metab."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(63)91624-6","volume":"1","author":"D. Janigan","year":"1963","unstructured":"Janigan, D.: Cytoplasmic bodies in the adrenal cortex of patients treated with spironolactone. Lancet1, 850?852 (1963)","journal-title":"Lancet"},{"key":"CR15","first-page":"219s","volume":"45","author":"F. Mantero","year":"1973","unstructured":"Mantero, F., Armanini, D., Urbani, S.: Antihypertensive effect of spironolactone in essential, renal and mineralocorticoid hypertension. Clin. Mol. Med.45, 219s-224s (1973)","journal-title":"Clin. Mol. Med."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0022-4731(76)90190-4","volume":"7","author":"P. Mason","year":"1976","unstructured":"Mason, P., Fraser, R., Morton, J., Semple, P., Wilson, A.: The effect of angiotensin II infusion on plasma corticosteroid concentrations in normal man. J. Steroid Biochem.7, 859?861 (1976)","journal-title":"J. Steroid Biochem."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1210\/jcem-39-5-882","volume":"39","author":"W. Oelkers","year":"1974","unstructured":"Oelkers, W., Sch\ufffdnesh\ufffdfer, M., Bl\ufffdmel, A.: Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man. J. clin. Endocrinol. Metab.39, 882?890 (1974)","journal-title":"J. clin. Endocrinol. Metab."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/jps.2600610719","volume":"61","author":"W. Sad\ufffde","year":"1972","unstructured":"Sad\ufffde, W., Dagcioglu, M., Riegelman, S.: Fluorimetric microassay for spironolactone and its metabolites in biological fluids. J. Pharm. Sci.61, 1126?1129 (1972)","journal-title":"J. Pharm. Sci."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1210\/jcem-39-4-734","volume":"39","author":"J. Sundsfjord","year":"1974","unstructured":"Sundsfjord, J., Marton, P., Jorgensen, H., Aakvaag, A.: Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism. J. clin. Endocrinol. Metab.39, 734?739 (1974)","journal-title":"J. clin. Endocrinol. Metab."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0022-4731(77)90199-6","volume":"8","author":"M. Sch\ufffdnesh\ufffdfer","year":"1977","unstructured":"Sch\ufffdnesh\ufffdfer, M.: Simultaneous determination of eight adrenal steroids in human serum by radioimmunoassay. J. Steroid Biochem.8, 995?1009 (1977)","journal-title":"J. Steroid Biochem."},{"issue":"Suppl.","key":"CR21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1530\/acta.0.080S116","volume":"193","author":"M. Sch\ufffdnesh\ufffdfer","year":"1975","unstructured":"Sch\ufffdnesh\ufffdfer, M.: Suitability of four standard curve models for computer evaluation of steroid and peptide radioimmunoassays. Acta endocr. (Kbh), Suppl.193, 116 (1975)","journal-title":"Acta endocr. (Kbh)"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/BF01931912","volume":"28","author":"P. Vecsei","year":"1972","unstructured":"Vecsei, P., Penke, B., Joumaah, A.: Radio immunoassay of free aldosterone and of its 18-oxo-glucuronide in humane urine. Experientia28, 622?624 (1972)","journal-title":"Experientia"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF01468678","volume":"53","author":"H. Vetter","year":"1975","unstructured":"Vetter, H., Vetter, W.: Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication. Klin. Wschr.53, 391?393 (1975)","journal-title":"Klin. Wschr."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000178776","volume":"8","author":"H. Vetter","year":"1977","unstructured":"Vetter, H., Appenheimer, M., Lucas, R., Weiand, H., Herschbach, M.L., Gl\ufffdnzer, K., Witassek, F., Kr\ufffdck, F.: Effect of spirolactone on plasma and urinary aldosterone in primary aldosteronism. Horm. Res.8, 23?28 (1977)","journal-title":"Horm. Res."}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01477405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01477405\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01477405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T11:32:12Z","timestamp":1556883132000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01477405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,2]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1979,2]]}},"alternative-id":["BF01477405"],"URL":"https:\/\/doi.org\/10.1007\/bf01477405","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979,2]]}}}